2026 -- S 2010 | |
======== | |
LC003250 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2026 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- THE TRANSPARENCY AND ACCOUNTABILITY IN | |
ARTIFICIAL INTELLIGENCE USE BY HEALTH INSURERS TO MANAGE COVERAGE | |
AND CLAIMS ACT | |
| |
Introduced By: Senators Ujifusa, Gu, Ciccone, Lawson, Tikoian, DiMario, Valverde, | |
Date Introduced: January 09, 2026 | |
Referred To: Senate Artificial Intelligence & Emerging Tech | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Title 27 of the General Laws entitled "INSURANCE" is hereby amended by |
2 | adding thereto the following chapter: |
3 | CHAPTER 84 |
4 | THE TRANSPARENCY AND ACCOUNTABILITY IN ARTIFICIAL INTELLIGENCE USE |
5 | BY HEALTH INSURERS TO MANAGE COVERAGE AND CLAIMS ACT |
6 | 27-84-1. Short title and purpose. |
7 | (a) This chapter shall be known and may be cited as "The Transparency and Accountability |
8 | in Artificial Intelligence Use by Health Insurers to Manage Coverage and Claims Act." |
9 | (b) The purpose of this chapter is to regulate the use of artificial intelligence ("AI") by |
10 | health insurers to ensure transparency, accountability and compliance with state and federal |
11 | requirements for non-administrative claims and coverage management. |
12 | 27-84-2. Definitions. |
13 | As used in this chapter, the following terms shall have the following meanings, unless the |
14 | context clearly indicates otherwise: |
15 | (1) "Adverse benefit determination" means a decision not to authorize coverage for a |
16 | healthcare service, including a denial, reduction, or termination of, or a failure to provide or make |
17 | a payment, in whole or in part, for a benefit. A decision by a utilization-review agent to authorize |
18 | a healthcare service in an alternative setting, a modified extension of stay, or an alternative |
| |
1 | treatment shall not constitute an adverse benefit determination if the review agent and ordering |
2 | provider are in agreement regarding the decision. "Adverse benefit determination" includes: |
3 | (i) "Administrative adverse benefit determination," meaning any adverse benefit |
4 | determination that does not require the use of medical judgment or clinical criteria such as a |
5 | determination of an individual's eligibility to participate in coverage, a determination that a benefit |
6 | is not a covered benefit, or any rescission of coverage; and |
7 | (ii) "Non-administrative adverse benefit determination," meaning any adverse benefit |
8 | determination that requires or involves the use of medical judgement or clinical criteria to |
9 | determine whether the service being reviewed is medically necessary and/or appropriate. This |
10 | determination includes the denial of treatments determined to be experimental or investigational, |
11 | and any denial of coverage of a prescription drug due to the fact that the drug is not on the insurer's |
12 | formulary. |
13 | (2) "Artificial intelligence" means a machine-based system that can, for a given set of |
14 | human-defined objectives, make predictions, recommendations or decisions influencing real or |
15 | virtual environments. Artificial intelligence systems use machine and human-based inputs to: |
16 | (i) Perceive real and virtual environments; |
17 | (ii) Abstract such perceptions into models through analysis in an automated manner; and |
18 | (iii) Use model inference to formulate options for information or action. |
19 | (3) "Enrollee" means an individual who has health insurance coverage through an insurer. |
20 | (4) "Insurer" means an insurance company licensed, or required to be licensed, by the State |
21 | of Rhode Island or other entity subject to the jurisdiction of the commissioner or the jurisdiction of |
22 | the department of business regulation pursuant to chapter 62 of title 42, that contracts or offers to |
23 | contract, or enters into an agreement to provide, deliver, arrange for, pay for, or reimburse any of |
24 | the costs of healthcare services, including, without limitation: a for-profit or nonprofit hospital, |
25 | medical or dental service corporation or plan, a health maintenance organization, a health insurance |
26 | company, or any other entity providing a plan of health insurance, accident and sickness insurance, |
27 | health benefits, or healthcare services including, but not limited to, pharmacy benefit managers. |
28 | (5) "Medically necessary care" means a medical, surgical, or other service required for the |
29 | prevention, diagnosis, cure, or treatment of a health-related condition including any such services |
30 | that are necessary to prevent or slow a decremental change in either medical or mental health status. |
31 | (6) "Provider" means a physician, hospital, professional provider, pharmacy, laboratory, |
32 | dental, medical, or behavioral health provider or other state-licensed or other state-recognized |
33 | provider of health care or behavioral health services or supplies. |
34 | 27-84-3. Requirements. |
| LC003250 - Page 2 of 5 |
1 | (a) Transparency. |
2 | (1) Insurers subject to this chapter shall disclose to the office of the health insurance |
3 | commissioner ("OHIC") and the department of business regulation ("DBR") how they use artificial |
4 | intelligence to manage healthcare claims and coverage including, but not limited to, the types of |
5 | artificial intelligence models used, the role of artificial intelligence in the decision-making process, |
6 | training datasets, performance metrics, governance and risk management policies, and the decisions |
7 | on healthcare claims and coverage where artificial intelligence made, or was a substantial factor in |
8 | making, the decisions. |
9 | (2) Insurers shall submit to the office of the health insurance commissioner and the |
10 | department of business regulation, upon request, all information, including documents and |
11 | software, that permits enforcement of this chapter. |
12 | (3) Insurers shall maintain documentation of artificial intelligence decisions for at least five |
13 | (5) years including adverse benefit determinations where artificial intelligence made, or was a |
14 | substantial factor in making, the adverse benefit determination. |
15 | (b) DBR/OHIC reporting. |
16 | (1) DBR/OHIC shall provide an initial report to the governor, the senate president and the |
17 | speaker of the house on the use of artificial intelligence by health insurers within eighteen (18) |
18 | months of the effective date of this chapter and annually thereafter. |
19 | (2) The annual report shall state how health insurers use artificial intelligence to manage |
20 | claims and coverage. The report shall state, for each insurer: |
21 | (i) The types of artificial intelligence models used; |
22 | (ii) The role of artificial intelligence in the decision-making process to approve or deny |
23 | healthcare claims or coverage whenever artificial intelligence is used to make, or is a substantial |
24 | factor in making, a decision on healthcare claims or coverage; |
25 | (iii) Information regarding training. testing, and risk management including data |
26 | governance measures used to cover the training data sets and the measures used to examine the |
27 | suitability of data sources, possible biases and appropriate mitigation; and |
28 | (iv) Performance metrics including: number of claims; percentage of claims accepted and |
29 | denied; the average time claim reviewers and medical professional reviewers spend on each claim |
30 | and on denials of claims; percentage of claims appealed; and percentage of denials reversed. |
31 | 27-84-4. Non-administrative adverse benefit determination review. |
32 | (a) Any non-administrative adverse benefit determination where an artificial intelligence |
33 | system made, or was a substantial factor in making, that determination regarding medically |
34 | necessary care shall be reviewed and approved by a provider with the same license status of the |
| LC003250 - Page 3 of 5 |
1 | ordering professional provider before being finalized, with documentation of their rationale |
2 | included in the enrolleeās case record. Failure to follow the requirements set forth in this subsection |
3 | shall result in reversal of the non-administrative adverse determination. |
4 | (b) Appeals of non-administrative adverse benefit determinations made by an artificial |
5 | intelligence system regarding medically necessary care that has been reviewed and approved by a |
6 | provider with the same license status of the ordering professional provider shall comply with the |
7 | appeals process set forth in chapter 18.9 of title 27. |
8 | 27-84-5. Enforcement. |
9 | (a) OHIC, in collaboration with DBR, shall promulgate rules and regulations that may be |
10 | necessary to effectuate the purposes and implementation of this chapter. |
11 | (b) The total cost of complying with the requirements of this chapter and the applicable |
12 | rules and regulations shall be borne by the insurer. |
13 | 27-84-6. Severability. |
14 | If any provision of this chapter is found unconstitutional, preempted, or otherwise invalid, |
15 | that provision shall be severed, and such decision shall not affect the validity of the remaining |
16 | provisions of this chapter. |
17 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC003250 | |
======== | |
| LC003250 - Page 4 of 5 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- THE TRANSPARENCY AND ACCOUNTABILITY IN | |
ARTIFICIAL INTELLIGENCE USE BY HEALTH INSURERS TO MANAGE COVERAGE | |
AND CLAIMS ACT | |
*** | |
1 | This act would promote transparency and accountability in the use of artificial intelligence |
2 | by health insurers to manage coverage and claims. |
3 | This act would take effect upon passage. |
======== | |
LC003250 | |
======== | |
| LC003250 - Page 5 of 5 |